A California company is working on a way to counter the blood-thinning effects of Xarelto and Eliquis, two competitors to Pradaxa, a drug currently the subject of lawsuits in the U.S. District Court for the Southern District of Illinois (MDL-2385), according to a Med Page Today report. However, the Rottenstein Law Group notes with concern that the antidote would not work with Pradaxa, whose side effects include excessive bleeding.
(PRWeb February 06, 2013)
Read the full story at http://www.prweb.com/releases/pradaxa-side-effects/pradaxa-lawsuits/prweb10405527.htm
